Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Modeling performance of a two-dimensional capsule in a microchannel flow: long-term lateral migration.

Physical review. E, Statistical, nonlinear, and soft matter physics·2010

Same author

Neuroprotective effects of resveratrol on ischemic injury mediated by improving brain energy metabolism and alleviating oxidative stress in rats.

Neuropharmacology·2010

Same author

[Determination of prim-O-glucosylcimifugin and 5-O-methylvisammisoide in Saposhnikovia divaricata and HPLC fingerprint analysis].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2010

Same author

Chronic treatment of exendin-4 affects cell proliferation and neuroblast differentiation in the adult mouse hippocampal dentate gyrus.

Neuroscience letters·2010

Same author

Design, synthesis and activity of benzothiazole-based inhibitors of NO production in LPS-activated macrophages.

Bioorganic & medicinal chemistry letters·2010

Same author

Tuberculosis should not be ignored in patients with peripheral gangrene.

Journal of vascular surgery·2010

Same journal

PROTAC technology for prostate cancer treatment.

Acta materia medica·2025

Same journal

New generation estrogen receptor-targeted agents in breast cancer: present situation and future prospectives.

Acta materia medica·2024

Same journal

PROTACs Targeting Epigenetic Proteins.

Acta materia medica·2024

Same journal

Statistical Evaluation of Absolute Change versus Responder Analysis in Clinical Trials.

Acta materia medica·2023

Same journal

The 'New (Nu)-clear' evidence for the tumor-driving role of PI3K.

Acta materia medica·2023

Same journal

MDM2-BCL-X<sub>L</sub> PROTACs enable degradation of BCL-X<sub>L</sub> and stabilization of p53.

Acta materia medica·2023

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 11, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

Application of PROTACs in Target Identification and Target Validation.

Yang Liu¹, Jing Liang¹, Rui Zhu¹

¹Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, 110016, China.

Acta Materia Medica

|October 7, 2024

Summary

This summary is machine-generated.

Proteolysis-targeting chimeras (PROTACs) are emerging as powerful tools for drug discovery. This review details their progress in target identification and validation, highlighting their potential in medicine.

Keywords:

PROTAC Probe Target identification Target validation

More Related Videos

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Related Experiment Videos

Last Updated: Jun 11, 2025

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Area of Science:

Chemical Biology
Drug Discovery
Molecular Pharmacology

Background:

Proteolysis-targeting chimeras (PROTACs) are a novel therapeutic modality.
PROTACs offer unique mechanisms for protein degradation and dynamic regulation.
Their development has significant implications for the pharmaceutical industry and academic research.

Purpose of the Study:

To review the advancements of PROTAC technology in drug discovery.
To differentiate the concepts of target identification and target validation.
To summarize PROTAC applications in basic medical sciences.

Main Methods:

Literature review of PROTAC technology.
Analysis of PROTAC applications in target identification.
Analysis of PROTAC applications in target validation.

Main Results:

PROTACs are increasingly vital for target identification and validation.
The review clarifies the distinct roles of PROTACs in these processes.
PROTAC technology shows significant progress and broad applicability.

Conclusions:

PROTACs are essential tools for modern drug discovery.
Understanding PROTACs' role in target identification and validation is crucial.
Further application of PROTACs will accelerate biomedical research.